Physician Assistant · Houston, TX
NPI
1922216407
Since 2007
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9055 Katy Fwy Ste 306
Houston, TX, 77024
Phone (713) 468-5009
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,642 services
Medicare patients, 2024
206
Average age 73
Drug cost, 2024
$2.6M
5,768 prescriptions
Company payments, 2025
$2,481
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tiffanie B Villasana was code 99214 (office e&m - established), 510 times for 196 patients. In total Tiffanie B Villasana billed 2,642 services in 35 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 510 | 196 | $80.90 | $41K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 457 | 202 | $10.58 | $4,833 |
| 95251 Test - Miscellaneous | Office | 263 | 78 | $22.43 | $5,900 |
| 80053 Clinical Chemistry | Office | 188 | 127 | $10.30 | $1,936 |
| 84443 Clinical Chemistry | Office | 178 | 121 | $16.38 | $2,915 |
| 84439 Clinical Chemistry | Office | 172 | 116 | $8.79 | $1,512 |
| 84481 Clinical Chemistry | Office | 172 | 116 | $16.51 | $2,840 |
| 83036 Blood Count | Office | 165 | 114 | $9.47 | $1,562 |
| 80061 Clinical Chemistry | Office | 83 | 70 | $12.98 | $1,077 |
| 82043 Clinical Chemistry | Office | 44 | 44 | $5.66 | $249 |
| 82570 Clinical Chemistry | Office | 43 | 43 | $5.08 | $218 |
| 82306 Clinical Chemistry | Office | 36 | 35 | $29.01 | $1,044 |
| 85025 Blood Count | Office | 24 | 23 | $7.61 | $183 |
| 99204 Office E&M - New | Office | 19 | 19 | $101.13 | $1,921 |
| 99213 Office E&M - Established | Office | 11 | 11 | $44.97 | $495 |
By year: 2022 $59K for 1,876 services; 2023 $60K for 1,952 services; 2024 $71K for 2,642 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 188 | 127 | $10.30 | $1,936 |
| 84443 Clinical Chemistry | 178 | 121 | $16.38 | $2,915 |
| 84481 Clinical Chemistry | 172 | 116 | $16.51 | $2,840 |
| 84439 Clinical Chemistry | 172 | 116 | $8.79 | $1,512 |
| 83036 Blood Count | 165 | 114 | $9.47 | $1,562 |
| 80061 Clinical Chemistry | 83 | 70 | $12.98 | $1,077 |
| 82043 Clinical Chemistry | 44 | 44 | $5.66 | $249 |
| 82570 Clinical Chemistry | 43 | 43 | $5.08 | $218 |
| 82306 Clinical Chemistry | 36 | 35 | $29.01 | $1,044 |
| 85025 Blood Count | 24 | 23 | $7.61 | $183 |
Medicare prescription drug claims, 2024
In 2024, the drug Tiffanie B Villasana prescribed most often to Medicare patients was Metformin Hcl Er (Metformin Hcl), with 415 prescriptions and refills. In total Tiffanie B Villasana wrote 5,768 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Er Metformin Hcl | 415 | 1,193 | 135 | $5,617 |
| Ozempic Semaglutide | 322 | 520 | 75 | $490K |
| Levothyroxine Sodium Generic | 303 | 779 | 94 | $2,505 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 255 | 357 | 51 | $247K |
| Farxiga Dapagliflozin Propanediol | 230 | 368 | 61 | $197K |
| Levoxyl Levothyroxine Sodium | 221 | 529 | 61 | $8,797 |
| Synthroid Levothyroxine Sodium | 221 | 588 | 65 | $25K |
| Rosuvastatin Calcium Generic | 215 | 586 | 76 | $2,475 |
| Jardiance Empagliflozin | 205 | 370 | 47 | $209K |
| Unithroid Levothyroxine Sodium | 200 | 482 | 49 | $5,720 |
| Mounjaro Tirzepatide | 186 | 237 | 44 | $243K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 172 | 264 | 38 | $274K |
| Gabapentin Generic | 152 | 317 | 49 | $2,325 |
| Atorvastatin Calcium Generic | 150 | 401 | 51 | $1,222 |
| Metformin Hcl Generic | 142 | 384 | 46 | $1,110 |
Brand drugs: 3,107 claims; generic drugs: 2,417 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tiffanie B Villasana $2,481 ($2,481 in general payments such as food, travel and fees) from 25 companies. The largest payer was Corcept Therapeutics with $287.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 18 | $287 |
| Insulet Corporation PODD | 26 | $247 |
| Abbott Laboratories ABT | 14 | $209 |
| Novo Nordisk Inc NVO | 10 | $201 |
| Currax Pharmaceuticals LLC | 20 | $168 |
| Amneal Pharmaceuticals LLC AMRX | 11 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $127 |
| Tandem Diabetes Care, Inc. TNDM | 4 | $113 |
| Lilly USA, LLC LLY | 6 | $110 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.